Szota, A.M.; Ćwiklińska-Jurkowska, M.; Radajewska, I.; Lis, K.; Grudzka, P.; Dróżdż, W.
Effect of Electroconvulsive Therapy (ECT) on IL-1β, IP-10, IL-17, TNFα, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) Patients—A Preliminary Study. J. Clin. Med. 2025, 14, 3170.
https://doi.org/10.3390/jcm14093170
AMA Style
Szota AM, Ćwiklińska-Jurkowska M, Radajewska I, Lis K, Grudzka P, Dróżdż W.
Effect of Electroconvulsive Therapy (ECT) on IL-1β, IP-10, IL-17, TNFα, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) Patients—A Preliminary Study. Journal of Clinical Medicine. 2025; 14(9):3170.
https://doi.org/10.3390/jcm14093170
Chicago/Turabian Style
Szota, Anna Maria, Małgorzata Ćwiklińska-Jurkowska, Izabela Radajewska, Kinga Lis, Przemysław Grudzka, and Wiktor Dróżdż.
2025. "Effect of Electroconvulsive Therapy (ECT) on IL-1β, IP-10, IL-17, TNFα, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) Patients—A Preliminary Study" Journal of Clinical Medicine 14, no. 9: 3170.
https://doi.org/10.3390/jcm14093170
APA Style
Szota, A. M., Ćwiklińska-Jurkowska, M., Radajewska, I., Lis, K., Grudzka, P., & Dróżdż, W.
(2025). Effect of Electroconvulsive Therapy (ECT) on IL-1β, IP-10, IL-17, TNFα, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) Patients—A Preliminary Study. Journal of Clinical Medicine, 14(9), 3170.
https://doi.org/10.3390/jcm14093170